Novel sulfoglycolipid IG20 causes neuroprotection by activating the phase II antioxidant response in rat hippocampal slices
Entity
UAM. Departamento de FarmacologíaPublisher
ElsevierDate
2017-04-01Citation
10.1016/j.neuropharm.2016.12.016
Neuropharmacology 116 (2017): 110-121
ISSN
0028-3908 (print); 1873-7064 (online)DOI
10.1016/j.neuropharm.2016.12.016Funded by
This study was supported by a grant from Ministerio de Economía y Competitividad, Spain (MINECO SAF2013-44108-P to AGG and LG; MAT2015-65184-C2-2-R to AFM, CABICYC UAM-Bioiberica and European Commission-ERC, People (Marie Curie Actions) FP7 under REA grant agreement n PCIG11-GA-2012-322156; Spanish Ministry of Health (Instituto de Salud Carlos III) (grant PI14/00372) and Miguel Servet (CP11/00165); Bayer A.G., “From Targets to Novel Drugs” program (grant 2015-03-1282) and Fundacion FIPSE (grant 12-00001344-15) to RL. RL thanks IS Carlos III for research contract under Miguel Servet Program. P.M. thanks MECD for FPU fellowship (AP2010-1219)Project
Gobierno de España. SAF2013-44108; Gobierno de España. MAT2015-65184-C2-2-R; info:eu-repo/grantAgreement/EC/FP7/322156Editor's Version
https://doi.org/10.1016/j.neuropharm.2016.12.016Subjects
Hippocampal neurons; Hippocampal slices; Neuronal excitability; Neuroprotection; Neurotoxicity; Oxidative stress; Sulfoglycolipid IG20; MedicinaNote
Los datos de investigación asociados a este artículo están disponibles en http://dx.doi.org/10.1016/j.neuropharm.2016.12.016Rights
© 2016 Elsevier Ltd.Esta obra está bajo una licencia de Creative Commons Reconocimiento-NoComercial-SinObraDerivada 4.0 Internacional.
Abstract
Compound IG20 is a newly synthesised sulphated glycolipid that promotes neuritic outgrowth and myelinisation, at the time it causes the inhibition of glial proliferation and facilitates exocytosis in chromaffin cells. Here we have shown that IG20 at 0.3–10 μM afforded neuroprotection in rat hippocampal slices stressed with veratridine, glutamate or with oxygen plus glucose deprivation followed by reoxygenation (OGD/reox). Excess production of reactive oxygen species (ROS) elicited by glutamate or ODG/reox was prevented by IG20 that also restored the depressed tissue levels of GSH and ATP in hippocampal slices subjected to OGD/reox. Furthermore, the augmented iNOS expression produced upon OGD/reox exposure was also counteracted by IG20. Additionally, the IG20 elicited neuroprotection was prevented by the presence of inhibitors of the signalling pathways Jak2/STAT3, MEK/ERK1/2, and PI3K/Akt, consistent with the ability of the compound to increase the phosphorylation of Jak2, ERK1/2, and Akt. Thus, the activation of phase II response and the Nrf2/ARE pathway could explain the antioxidant and anti-inflammatory effects and the ensuing neuroprotective actions of IG20
Files in this item
Google Scholar:Punzón, Eva
-
García-Alvarado, Fernanda
-
Maroto, Marcos
-
Fernández-Mendívil, Cristina
-
Michalska, Patrycja
-
García-Álvarez, Isabel
-
Arranz-Tagarro, Juan Alberto
-
Buendía, Izaskun
-
López, Mauela G.
-
León, Rafael
-
Gandía Juan, Luis
-
Fernández-Mayoralas, Alfonso
-
García, Antonio G.
This item appears in the following Collection(s)
Related items
Showing items related by title, author, creator and subject.
-
Tuning melatonin receptor subtype selectivity in oxadiazolone-based analogues: Discovery of QR2 ligands and NRF2 activators with neurogenic properties
Herrera-Arozamena, Clara; Estrada-Valencia, Martín; Pérez, Concepción; Lagartera, Laura; Morales-García, José A.; Pérez-Castillo, Ana; Franco-Gonzalez, Juan Felipe; Michalska, Patrycja; Duarte, Pablo; León, Rafael; López, Manuela G.; Mills, Alberto; Gago, Federico; García-Yagüe, Ángel Juan; Fernández-Ginés, Raquel; Cuadrado Pastor, Antonio; Rodríguez-Franco, María Isabel
2020-01-25